Advertisement

Latest News

Self-Administered Nasal Etripamil Restores Sinus Rhythm Safely, With James Ip, MD

2 hours ago

Ip highlights the uniform safety of patient-administered etripamil nasal spray across a series of phase 2 and 3 studies.

SCALE-UP: Findings on Real-World Use of Upadacitinib in Atopic Dermatitis

3 hours ago

The SCALE-UP study, assessing patients with atopic dermatitis treated with upadacitinib, points to rapid real‐world efficacy findings on this medication.

Povorcitinib 75 mg Rapidly Reduces Itch and Hives in CSU, With Jonathan Bernstein, MD

5 hours ago

New phase 2 data reveals povorcitinib effectively reduces itch and hives in chronic spontaneous urticaria, showing promise as a treatment option.

Clinical Pearls in Pediatric Dermatology Highlighted in 2025 Fall Clinical Conference

6 hours ago

At the Fall Clinical Dermatology Conference, this session provided clinical pearls to clinicians in the pediatric dermatology space.

Understanding HU6 and Its Emerging Role in MASH, With Mazen Noureddin, MD, MHSc

6 hours ago

Noureddin explains HU6’s mechanism of action and phase 2 data presented at AASLD The Liver Meeting supporting its use in MASH.

Advertisement
Advertisement